Vaxil Bio Ltd.

OTCPK:VXLL.F Stock Report

Market Cap: US$1.0m

Vaxil Bio Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

David Goren

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure6.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Goren's remuneration changed compared to Vaxil Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-CA$187k

Dec 31 2023n/an/a

-CA$254k

Sep 30 2023n/an/a

-CA$453k

Jun 30 2023n/an/a

-CA$564k

Mar 31 2023n/an/a

-CA$583k

Dec 31 2022n/an/a

-CA$584k

Sep 30 2022n/an/a

-CA$691k

Jun 30 2022n/an/a

-CA$791k

Mar 31 2022n/an/a

-CA$854k

Dec 31 2021CA$103kCA$63k

-CA$986k

Sep 30 2021n/an/a

-CA$1m

Jun 30 2021n/an/a

-CA$1m

Mar 31 2021n/an/a

-CA$1m

Dec 31 2020CA$244kCA$102k

-CA$1m

Sep 30 2020n/an/a

-CA$1m

Jun 30 2020n/an/a

-CA$1m

Mar 31 2020n/an/a

-CA$1m

Dec 31 2019CA$242kCA$100k

-CA$1m

Sep 30 2019n/an/a

-CA$1m

Jun 30 2019n/an/a

-CA$1m

Mar 31 2019n/an/a

-CA$1m

Dec 31 2018CA$128kCA$33k

-CA$1m

Compensation vs Market: Insufficient data to establish whether David's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.

CEO

David Goren

no data

Tenure

CA$103,000

Compensation

Mr. David Goren had been the Chief Executive Officer of Vaxil Bio Ltd. since September 2018 until August 2021 and had been its Chairman since August 2019 until August 2021. He serves as Chief Executive Off...

Board Members

NamePositionTenureCompensationOwnership
David Goren
CEO & Chairmanno dataCA$103.00kno data
Gadi Levin
CFO & Directorno dataCA$98.00k0.55%
$ 5.6k
Riva Kovjazin
Senior Scientist & Member of Scientific Advisory Boardno datano datano data
Michael Berelowitz
Special Advisor to the Board3.5yrsno datano data
Ari Kellen
Independent Director & Member of Scientific Advisory Board6.7yrsno data4.05%
$ 40.6k
Shawn Langer
Independent Director & Member of Scientific Advisory Board6.7yrsno data3.64%
$ 36.6k

6.7yrs

Average Tenure

61yo

Average Age

Experienced Board: VXLL.F's board of directors are considered experienced (6.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/08/20 15:34
End of Day Share Price 2024/05/23 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vaxil Bio Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution